145 related articles for article (PubMed ID: 18536822)
21. ACE gene polymorphism and renal responsiveness to ACE inhibitors in IgA nephropathy patients.
Han SY; Kwon YJ; Jo SK; Shin JH; Cha DR; Cho WY; Pyo HJ; Kim HK
Korean J Intern Med; 2000 Jan; 15(1):13-8. PubMed ID: 10714086
[TBL] [Abstract][Full Text] [Related]
22. 3rd College of Physicians' lecture--translational research: From bench to bedside and from bedside to bench; incorporating a clinical research journey in IgA nephritis (1976 to 2006).
Woo KT; Lau YK; Yap HK; Lee GS; Choong HL; Vathsala A; Chiang GS; Lee EJ; Wong KS; Lim CH
Ann Acad Med Singap; 2006 Oct; 35(10):735-41. PubMed ID: 17102900
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for IgA nephropathy in children.
Vaz de Castro PAS; Bitencourt L; Pereira BWS; Lima AQR; Hermida HS; Moreira Neto CR; Mestriner MD; Simões E Silva AC
Pediatr Nephrol; 2022 Mar; 37(3):499-508. PubMed ID: 34686915
[TBL] [Abstract][Full Text] [Related]
24. Long-term treatment by ACE inhibitors and angiotensin receptor blockers in children with Alport syndrome.
Zhang Y; Wang F; Ding J; Zhang H; Liu X; Wang S; Xiao H; Yao Y; Liu J; Zhong X; Guan N; Su B; Wu G; Yu L
Pediatr Nephrol; 2016 Jan; 31(1):67-72. PubMed ID: 26248473
[TBL] [Abstract][Full Text] [Related]
25. Polymorphism of renin-angiotensin system genes in IgA nephropathy.
Woo KT; Lau YK; Choong LH; Zhao Y; Tan HB; Fook-Chong S; Tan EK; Yap HK; Wong KS
Nephrology (Carlton); 2004 Oct; 9(5):304-9. PubMed ID: 15504143
[TBL] [Abstract][Full Text] [Related]
26. Dual blockade of the renin-angiotensin system compared with a 50% increase in the dose of angiotensin-converting enzyme inhibitor: effects on proteinuria and blood pressure.
Kincaid-Smith P; Fairley KF; Packham D
Nephrol Dial Transplant; 2004 Sep; 19(9):2272-4. PubMed ID: 15252156
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin-converting enzyme gene polymorphism is correlated to the progression of disease in patients with IgA nephropathy: a meta-analysis.
Wiwanitkit V
Ren Fail; 2006; 28(8):697-9. PubMed ID: 17162429
[TBL] [Abstract][Full Text] [Related]
28. ACE gene polymorphism and disease progression of IgA nephropathy in Asians in Singapore.
Lau YK; Woo KT; Choong HL; Zhao Y; Tan HB; Cheung W; Yap HK
Nephron; 2002 Jul; 91(3):499-503. PubMed ID: 12119485
[TBL] [Abstract][Full Text] [Related]
29. Treatment of severe Henoch-Schönlein and immunoglobulin A nephritis. A single center experience.
Edström Halling S; Söderberg MP; Berg UB
Pediatr Nephrol; 2009 Jan; 24(1):91-7. PubMed ID: 18931859
[TBL] [Abstract][Full Text] [Related]
30. [Influence of angiotensin-converting enzyme gene polymorphism on the anti-proteinuria efficacy of angiotensin-converting enzyme inhibitor in Han nationality of southern Sichuan province in China].
Liu J; Wang M; Liu Q; Li Y; Peng B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Apr; 22(2):204-5. PubMed ID: 15793787
[TBL] [Abstract][Full Text] [Related]
31. [The effects of angiotensin-converting enzyme inhibitor on IgA nephropathy and the influencing factors].
Shi X; Chen X; Liu S; Zhuang Y; Zhang Y
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):399-403. PubMed ID: 12137603
[TBL] [Abstract][Full Text] [Related]
32. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
Zhou TB; Yin SS; Liang R
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):235-41. PubMed ID: 23060471
[TBL] [Abstract][Full Text] [Related]
33. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
[TBL] [Abstract][Full Text] [Related]
34. Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism.
Narita I; Goto S; Saito N; Song J; Omori K; Kondo D; Sakatsume M; Gejyo F
J Med Genet; 2003 Dec; 40(12):e130. PubMed ID: 14684698
[No Abstract] [Full Text] [Related]
35. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
Zivko M; Kusec R; Galesić K
Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
[TBL] [Abstract][Full Text] [Related]
36. [The relationship between polymorphism of angiotensin converting enzyme gene and cough caused by angiotensin converting enzyme inhibitors].
Yang SM; He QY; Miao YD
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Apr; 26(4):203-5. PubMed ID: 12901825
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker therapy for IgA nephropathy: A meta-analysis of randomized controlled trials.
Ji Y; Yang K; Xiao B; Lin J; Zhao Q; Bhuva MS; Yang H
J Cell Biochem; 2019 Mar; 120(3):3689-3695. PubMed ID: 30270542
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-converting enzyme gene polymorphisms in renal disease: clinically relevant?
Taal MW
Curr Opin Nephrol Hypertens; 2000 Nov; 9(6):651-7. PubMed ID: 11128428
[TBL] [Abstract][Full Text] [Related]
39. [A prospective study on the cough mechanism induced by angiotensin-converting enzyme inhibitors in patients with hypertension].
Ye RJ; He QY; Gai J; Shang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):581-4. PubMed ID: 15498266
[TBL] [Abstract][Full Text] [Related]
40. A Pooled Study of Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism in Relation to Risk, Pathology and Prognosis of Childhood Immunoglobulin A Vasculitis Nephritis.
Hui G; Cheng Z; Ran H; Ziwei W; Fang D
Biochem Genet; 2021 Feb; 59(1):202-218. PubMed ID: 32980913
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
